Literature DB >> 11006223

The role of cytotoxic T lymphocytes in corneal allograft rejection.

S Hegde1, J Y Niederkorn.   

Abstract

PURPOSE: Immunologic rejection constitutes a major barrier to the success of allogeneic corneal transplants, but the specific mediators and mechanisms of graft rejection are poorly understood. Several studies have implicated cytotoxic T-lymphocyte (CTL) responses, typically associated with CD8(+) T cells, in promoting corneal graft rejection. This study sought to test the hypothesis that CTLs are essential in promoting corneal graft rejection.
METHODS: BALB/c donor corneas were grafted orthotopically onto C57BL/6, perforin knockout, or CD8(+) T-cell knockout mice. The tempo and incidence of graft rejection were observed for each group. In separate experiments, donor-specific CTL and delayed-type hypersensitivity (DTH) responses were tested at the time of graft rejection by a standard chromium release assay and an ear swelling assay, respectively.
RESULTS: Perforin knockout and CD8(+) T-cell knockout mice were as effective as wild-type C57BL/6 control mice in rejecting BALB/c donor corneas. Furthermore, animals in all three groups were found to develop robust donor-specific DTH, not CTL, responses at the time of graft rejection. Histopathologically, the rejected corneas from all three groups contained a predominantly mononuclear cellular infiltrate.
CONCLUSIONS: This study rejects the hypothesis that CD8(+) CTLs are essential in promoting corneal graft rejection and instead further implicates donor-specific DTH reactions as the relevant immune response during graft failure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006223

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

2.  Paradigm shifts in the role of CD4+ T cells in keratoplasty.

Authors:  Khrishen Cunnusamy; Peter W Chen; Jerry Y Niederkorn
Journal:  Discov Med       Date:  2010-11       Impact factor: 2.970

3.  Different Innate Immune Responses in BALB/c and C57BL/6 Strains following Corneal Transplantation.

Authors:  Tim Bleul; Xinyu Zhuang; Antonia Hildebrand; Clemens Lange; Daniel Böhringer; Günther Schlunck; Thomas Reinhard; Thabo Lapp
Journal:  J Innate Immun       Date:  2020-09-09       Impact factor: 7.349

4.  Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.

Authors:  Ann J Ligocki; Joseph R Brown; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

5.  Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Authors:  N J Reyes; P W Chen; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-03-13       Impact factor: 8.086

6.  Quantitative evaluation of the corneal endothelium in the mouse after grafting.

Authors:  J Plskova; L Kuffova; M Filipec; V Holan; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

7.  Allergic airway hyperreactivity increases the risk for corneal allograft rejection.

Authors:  J Y Niederkorn; P W Chen; J Mellon; C Stevens; E Mayhew
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

8.  Prevention of corneal allograft rejection in a mouse model of high risk recipients.

Authors:  A Vítová; M Filipec; A Zajícová; M Krulová; V Holán
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

9.  Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants.

Authors:  Florence Boisgérault; Ying Liu; Nathalie Anosova; Reza Dana; Gilles Benichou
Journal:  Transplantation       Date:  2009-01-15       Impact factor: 4.939

10.  The role of ACAID and CD4+CD25+FOXP3+ regulatory T cells on CTL function against MHC alloantigens.

Authors:  Daniel R Saban; Janet Cornelius; Sharmila Masli; Johannes Schwartzkopff; Maire Doyle; Sunil K Chauhan; Ammon B Peck; Maria B Grant
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.